...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
1
Jan 08, 2018 10:01PM
2
Jan 09, 2018 08:26AM
1
Jan 09, 2018 09:52AM
2
Jan 09, 2018 10:05AM
3
Jan 09, 2018 10:11AM
2
Jan 09, 2018 11:37AM
4
Jan 09, 2018 11:37AM
3
Jan 09, 2018 12:04PM
1
Jan 09, 2018 12:14PM
4
Jan 09, 2018 12:17PM
2
Jan 09, 2018 12:21PM
2
Jan 09, 2018 12:25PM
1
Jan 09, 2018 12:45PM
1
Jan 09, 2018 02:29PM

Toinv, chicagoest may be on to something here. I am trying to recall the group conversation I was in within the last couple of years where it was determined that 208 could end up being marketed in several different jurisdictions long before the USA and Europe. As each country has its own process of approval it could be the case that one or more of them have enough data now and it just has to be presented to their specifications. It would be best if someone with more knowledge took over this conversation at this point.

dyodd

tada 

Share
New Message
Please login to post a reply